Clinical Trial Update: 05-001: Treatment of Acute Lymphoblastic Leukemia in Children [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a Phase 3 study evaluating treatment of acute lymphoblastic leukemia in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Drug/Agent Toxicity by Tissue/Organ, Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2017-06-14